CA2951386C - Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof - Google Patents

Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof Download PDF

Info

Publication number
CA2951386C
CA2951386C CA2951386A CA2951386A CA2951386C CA 2951386 C CA2951386 C CA 2951386C CA 2951386 A CA2951386 A CA 2951386A CA 2951386 A CA2951386 A CA 2951386A CA 2951386 C CA2951386 C CA 2951386C
Authority
CA
Canada
Prior art keywords
peptide
composition
subject
product
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2951386A
Other languages
English (en)
French (fr)
Other versions
CA2951386A1 (en
Inventor
Jie Zheng
Ann Marie KNOLHOFF
Eric Wayne BROWN
Timothy Ray CROLEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Health and Human Services
Original Assignee
United States Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of Health and Human Services filed Critical United States Department of Health and Human Services
Publication of CA2951386A1 publication Critical patent/CA2951386A1/en
Application granted granted Critical
Publication of CA2951386C publication Critical patent/CA2951386C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2951386A 2014-06-09 2015-06-09 Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof Active CA2951386C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462009467P 2014-06-09 2014-06-09
US62/009,467 2014-06-09
PCT/US2015/034859 WO2015191551A1 (en) 2014-06-09 2015-06-09 Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Publications (2)

Publication Number Publication Date
CA2951386A1 CA2951386A1 (en) 2015-12-17
CA2951386C true CA2951386C (en) 2020-10-27

Family

ID=53443015

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2951386A Active CA2951386C (en) 2014-06-09 2015-06-09 Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Country Status (6)

Country Link
US (2) US10118948B2 (enExample)
EP (1) EP3152224B1 (enExample)
JP (1) JP6698556B2 (enExample)
AU (1) AU2015274889B2 (enExample)
CA (1) CA2951386C (enExample)
WO (1) WO2015191551A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
WO2019028463A1 (en) * 2017-08-04 2019-02-07 Bioventures, Llc LINEAR LIPOPEPTIDE PAENIPEPTINS AND METHODS OF USE
EP4192847A1 (en) * 2020-08-10 2023-06-14 Università Cattolica del Sacro Cuore New antimicrobial peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762928A (en) 1997-06-05 1998-06-09 Campbell Soup Company Biocontrol agent for green mold disease of mushrooms
WO2006099306A2 (en) 2005-03-10 2006-09-21 Custom Medical Applications, Inc. Catheter connection hub
UA15147U (en) 2005-12-20 2006-06-15 Instex And Clinical Veterinary ôLACTOSPORö, A COMPLEX AGENT FOR PROPHYLAXIS AND TREATMENT OF CALVES GASTROINTESTINAL DISEASES
ATE505197T1 (de) 2006-09-28 2011-04-15 Univ Ohio State Res Found Antibiotische und antimikrobielle wirkstoffe sowie verfahren zu ihrer verwendung
MX356959B (es) 2011-05-20 2018-06-21 The Us Secretary Department Of Health & Human Services Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
WO2013086003A1 (en) * 2011-12-05 2013-06-13 The Ohio State University Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Also Published As

Publication number Publication date
US20170145057A1 (en) 2017-05-25
CA2951386A1 (en) 2015-12-17
AU2015274889B2 (en) 2019-01-17
EP3152224A1 (en) 2017-04-12
JP6698556B2 (ja) 2020-05-27
US10118948B2 (en) 2018-11-06
US20190016757A1 (en) 2019-01-17
US10906940B2 (en) 2021-02-02
WO2015191551A1 (en) 2015-12-17
AU2015274889A1 (en) 2017-01-05
JP2017530088A (ja) 2017-10-12
EP3152224B1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
EP2994154B1 (en) Antimicrobial peptide
KR102419616B1 (ko) 항균 요법
US11325955B2 (en) Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
US9017692B2 (en) Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
US11548916B2 (en) Anti-infective compound
US10906940B2 (en) Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
TR201815301T4 (tr) Antimikrobiyal peptit ve bunun kullanımları.
Baldassarre et al. Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections
US7176276B2 (en) Antimicrobial peptide and use thereof
EP3212661A1 (en) Cyclic antimicrobial pseudopeptides and uses thereof
JP4154218B2 (ja) 新規抗菌性ポリペプチドとその利用
KR101865782B1 (ko) 바실러스 아밀로리퀴파시엔스 k14로부터 단리된 신규 항균 펩타이드 및 그의 용도
WO2015099535A1 (en) Thrombocidin-derived antimicrobial peptides
Tamaki et al. Novel cycloundecapeptides related to gramicidin S with both high antibiotic activity and low hemolytic activity

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200521

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250513

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250513